|
|
R L Palmer-Crocker, C C Hughes, J S Pober
J Clin Invest. 1996;
98(3):604
doi:10.1172/JCI118829
Abstract |
Full text
| PDF
I
L-4 and IL-13 each act on human endothelial cells (ECs) to induce expression of vascular cell adhesion molecule-1. On hematopoietic cells. IL-4 responses may be mediated either through a pathway involving gc, the common signaling subunit of the IL-2, IL-4, IL-7, IL-9, and IL-15 receptors, or through a gc-independent pathway that may be alternatively activated by IL-13. We find that human ECs do not express gc, as detected by indirect immunofluorescence and FACS analysis or by a reverse transcription-PCR method. Like IL-4, IL-13 activates a protein tyrosine kinase that phosphorylates the IL-4R binding protein. In addition, we find that IL-4 and IL-13 each induce tyrosine phosphorylation of the JAK2 tyrosine kinase. Furthermore, both IL-4 and IL-13 induce binding of the Stat6 transcription factor to a consensus sequence oligonucleotide. We conclude that the IL-4 response of human ECs involves the IL-13 shared pathway that is independent of gc, and uses JAK2-Stat6 signaling.
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal.
Not all publishers participate in CrossRef, so this information is not comprehensive.
Additionally, data may not reflect the most current citations to this article,
and the data may differ from citation information available from other sources
(for example, Google Scholar, Web of Science, and Scopus).
Total citations by year
in CrossRef
Citations to this article
in CrossRef
(21)
| Title and authors |
Publication |
Year |
Comprehensive Physiology
Jordan S. Pober
|
Comprehensive Physiology
|
2011 |
IL-13 induces translocation of NF-κB in cultured human bronchial smooth muscle cells
Kumiko Goto, Yoshihiko Chiba, Miwa Misawa
|
Cytokine
|
2009 |
Interleukin-4 and Interleukin-13 Stimulate the Osteoclast Inhibitor Osteoprotegerin by Human Endothelial Cells Through the STAT6 Pathway
Nicola C Stein, Carmen Kreutzmann, Sara-Pia Zimmermann, Ute Niebergall, Lars Hellmeyer, Claudia Goettsch, Michael Schoppet, Lorenz C Hofbauer
|
Journal of Bone and Mineral Research
|
2008 |
STAT6 Mediates Apoptosis of Human Coronary Arterial Endothelial Cells by Interleukin-13
Yuki NISHIMURA, Takeaki NITTO, Teruo INOUE, Koichi NODE
|
Hypertens Res
|
2008 |
IL-13 Attenuates Vascular Tube Formation Via JAK2-STAT6 Pathway
Yuki Nishimura, Takeaki Nitto, Teruo Inoue, Koichi Node
|
Circ J
|
2008 |
Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells
Farbod Shojaei, Xiumin Wu, Ajay K Malik, Cuiling Zhong, Megan E Baldwin, Stefanie Schanz, Germaine Fuh, Hans-Peter Gerber, Napoleone Ferrara
|
Nat Biotechnol
|
2007 |
Assessment of signal transducer and activator of transcription 6 as a target of glucocorticoid action in human airway epithelial cells
N. M. Heller, S. Matsukura, S. N. Georas, M. R. Boothby, C. Stellato, R. P. Schleimer
|
Clin Exp Allergy
|
2004 |
Up-regulation of interleukin-13 receptor α1 on human keratinocytes in the skin of psoriasis and atopic dermatitis
Jongkonnee Wongpiyabovorn, Hajime Suto, Hiroko Ushio, Kenji Izuhara, Koichi Mitsuishi, Shigaku Ikeda, Atsuhito Nakao, Ko Okumura, Hideoki Ogawa
|
Journal of Dermatological Science
|
2003 |
Interleukins-4, -5, and -13: emerging therapeutic targets in allergic disease
Paul S Foster, Margarita Martinez-Moczygemba, David P Huston, David B Corry
|
Pharmacology & Therapeutics
|
2002 |
The mucosal immune system: from specialized immune defense to inflammation and allergy
H. Kiyono, M.-N. Kweon, T. Hiroi, I. Takahashi
|
Acta Odontol Scand
|
2001 |
|